4:51 PM
 | 
Jan 27, 2014
 |  BC Extra  |  Financial News

Dermatology play Revance sets IPO range

Revance Therapeutics Inc. (Newark, Calif.) amended its IPO on NASDAQ and now plans to sell 5 million shares at $14-$16....

Read the full 83 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >